Medicare's New RAPID Program Is a Breakthrough for Adults, but Pediatric Medical Devices Are Still Left Behind
⚡ What Happened
The new RAPID pathway introduced by CMS (Centers for Medicare & Medicaid Services) is designed to expedite Medicare reimbursement for breakthrough medical devices, but pediatric medical devices remain excluded. The pediatric and rare disease device pipeline is the smallest, slowest, and least capitalized in the industry, raising concerns that the institutional gap will widen further. The key question going forward is whether discussions around dedicated support programs for pediatric medical devices will gain momentum.
RAPID is a new Medicare add-on payment program that enables earlier reimbursement for innovative devices that have received FDA Breakthrough Device designation. However, since Medicare primarily covers adults aged 65 and older and people with disabilities, children—who fall under Medicaid's jurisdiction—are structurally unable to benefit from this program. Progress on pediatric medical devices has been slow even after the 2007 Pediatric Medical Device Safety and Improvement Act, and the FDA's Humanitarian Device Exemption (HDE) program has failed to incentivize corporate development due to the small market size. The essence of Eskandanian's argument is a warning about the imbalance: while institutional innovation advances for adults, children remain trapped in a structural blind spot of policy design. As CMS reforms proceed under the Trump administration, the risk of institutionalizing the deprioritization of pediatric healthcare is growing.
🔍 Behind this op-ed lies an existential crisis for the pediatric medical device industry. The adult market is worth hundreds of billions of dollars, while the pediatric market is extremely small and shunned by venture capital. When programs like RAPID apply only to the adult side, the maldistribution of development resources intensifies further, creating a real risk that pediatric innovation effectively grinds to a halt. Pediatric hospitals like Children's National, where Eskandanian is based, have been forced to undertake device development themselves, and this op-ed also serves as a lobbying document aimed at policymakers.
📰 Source: STAT News
🔮 Scenario Outlook
🎯 Incentive Map
| Player | True Incentive | Underlying Vulnerability | Predicted Action |
|---|---|---|---|
| CMS (Centers for Medicare & Medicaid Services) | Build a track record of RAPID program success to showcase the administration's healthcare reform achievements | Bureaucratic inertia and jurisdictional turf consciousness. The Medicare division has little motivation to step into pediatric issues under Medicaid's jurisdiction | Focus on adult-oriented RAPID program operations and shelve pediatric issues as "a Medicaid problem" |
| Pediatric Device Manufacturers & Children's Hospitals | Business continuity is untenable without institutional support; withdrawal is on the table if no policy changes occur | Lack of political influence. Small market size means limited lobbying resources | Continue shaping public opinion through media and academic channels, but fail to achieve short-term policy changes |
| Congress (especially members interested in pediatric healthcare) | Pediatric healthcare is a politically low-risk topic, but legislative priority is low | Fragmented attention. Easily overshadowed by major fiscal and national security agendas | Express sympathy but take no concrete legislative action within two weeks |
⚠️ Pre-Mortem — Conditions Under Which This Prediction Fails
- The op-ed gains widespread attention and a lawmaker issues an immediate response statement (though historically, an op-ed alone triggering a policy response within two weeks is extremely rare)
- Deliberations on expanding pediatric programs are already underway within CMS and are announced around the same time as the RAPID rollout—a possibility we may be overlooking
- The impact of media coverage is being underestimated, creating an excessive bias toward NO (though base-rate analysis supports a NO-leaning position)
Fear-Setting / When this prediction fails
- This probability fails if a bipartisan Congressional letter or bill addressing pediatric device reimbursement is introduced within 2 weeks, triggered by this op-ed.
- This probability fails if CMS had already been preparing a pediatric device initiative and announces it coincidentally within the forecast window.
- This probability fails if a major pediatric health crisis (e.g., device shortage) forces emergency policy action within the timeline.
Hit condition: HIT if the U.S. Congress or CMS issues an official review or statement on accelerating reimbursement for pediatric medical devices by May 22, 2026
Resolution date: 2026-05-22
